|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fanis P, Gillemans N, Aghajanirefah A,
Pourfarzad F, Demmers J, Esteghamat F, Vadlamudi RK, Grosveld F,
Philipsen S and van Dijk TB: Five friends of methylated chromatin
target of protein-arginine-methyltransferase[prmt]-1 (chtop), a
complex linking arginine methylation to desumoylation. Mol Cell
Proteomics. 11:1263–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Castle CD, Cassimere EK and Denicourt C:
LAS1L interacts with the mammalian Rix1 complex to regulate
ribosome biogenesis. Mol Biol Cell. 23:716–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Finkbeiner E, Haindl M and Muller S: The
SUMO system controls nucleolar partitioning of a novel mammalian
ribosome biogenesis complex. EMBO J. 30:1067–1078. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding J, Huang X, Shao N, Zhou H, Lee DF,
Faiola F, Fidalgo M, Guallar D, Saunders A, Shliaha PV, et al:
Tex10 coordinates epigenetic control of super-enhancer activity in
pluripotency and reprogramming. Cell Stem Cell. 16:653–668. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao W, Huang Y, Zhang J, Liu M, Ji H,
Wang C, Cao N, Li C, Xia Y, Jiang Q and Qin J: Polycomb group RING
finger proteins 3/5 activate transcription via an interaction with
the pluripotency factor Tex10 in embryonic stem cells. J Biol Chem.
292:21527–21537. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiang X, Deng L, Xiong R, Xiao D, Chen Z,
Yang F, Liu K and Feng G: Tex10 is upregulated and promotes cancer
stem cell properties and chemoresistance in hepatocellular
carcinoma. Cell Cycle. 17:1310–1318. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang D, Plukker JTM and Coppes RP: Cancer
stem cells with increased metastatic potential as a therapeutic
target for esophageal cancer. Semin Cancer Biol. 44:60–66. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ouzounova M, Lee E, Piranlioglu R, El
Andaloussi A, Kolhe R, Demirci MF, Marasco D, Asm I, Chadli A,
Hassan KA, et al: Monocytic and granulocytic myeloid derived
suppressor cells differentially regulate spatiotemporal tumour
plasticity during metastatic cascade. Nat Commun. 8:149792017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishay-Ronen D, Diepenbruck M, Kalathur
RKR, Sugiyama N, Tiede S, Ivanek R, Bantug G, Morini MF, Wang J,
Hess C and Christofori G: Gain fat-lose metastasis: Converting
invasive breast cancer cells into adipocytes inhibits cancer
metastasis. Cancer Cell. 35:17–32.e16. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiang X, Deng L, Zhang J, Zhang X, Lei T,
Luan G, Yang C, Xiao ZX and Li Q and Li Q: A distinct expression
pattern of cyclin K in mammalian testes suggests a functional role
in spermatogenesis. PLoS One. 9:e1015392014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maehara O, Suda G, Natsuizaka M, Ohnishi
S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, et al:
Fibroblast growth factor-2-mediated FGFR/Erk signaling supports
maintenance of cancer stem-like cells in esophageal squamous cell
carcinoma. Carcinogenesis. 38:1073–1083. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu YX, Chen DL, Wang DS, Chen LZ, Mo HY,
Sheng H, Bai L, Wu QN, Yu HE, Xie D, et al: Melatonin enhances
sensitivity to fluorouracil in oesophageal squamous cell carcinoma
through inhibition of Erk and Akt pathway. Cell Death Dis.
7:e24322016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iser IC, Ceschini SM, Onzi GR, Bertoni AP,
Lenz G and Wink MR: Conditioned medium from adipose-derived stem
cells (ADSCs) promotes epithelial-to-mesenchymal-like transition
(EMT-Like) in glioma cells in vitro. Mol Neurobiol. 53:7184–7199.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang HF, Wu C, Alshareef A, Gupta N, Zhao
Q, Xu XE, Jiao JW, Li EM, Xu LY and Lai R: The PI3K/AKT/c-MYC axis
promotes the acquisition of cancer stem-like features in esophageal
squamous cell carcinoma. Stem Cells. 34:2040–2051. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu X, Zhai Y, Kong P, Cui H, Yan T, Yang
J, Qian Y, Ma Y, Wang F, Li H, et al: FAT1 prevents epithelial
mesenchymal transition (EMT) via MAPK/ERK signaling pathway in
esophageal squamous cell cancer. Cancer Lett. 397:83–93. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen HA, Kuo TC, Tseng CF, Ma JT, Yang ST,
Yen CJ, Yang CY, Sung SY and Su JL: Angiopoietin-like protein 1
antagonizes MET receptor activity to repress sorafenib resistance
and cancer stemness in hepatocellular carcinoma. Hepatology.
64:1637–1651. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marquardt S, Solanki M, Spitschak A, Vera
J and Pützer BM: Emerging functional markers for cancer stem
cell-based therapies: Understanding signaling networks for
targeting metastasis. Semin Cancer Biol. 53:90–109. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loureiro R, Mesquita KA, Magalhães-Novais
S, Oliveira PJ and Vega-Naredo I: Mitochondrial biology in cancer
stem cells. Semin Cancer Biol. 47:18–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nagle PW, Plukker JTM, Muijs CT, van Luijk
P and Coppes RP: Patient-derived tumor organoids for prediction of
cancer treatment response. Semin Cancer Biol. 53:258–264. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen L, Li YC, Wu L, Yu GT, Zhang WF,
Huang CF and Sun ZJ: TRAF6 regulates tumour metastasis through EMT
and CSC phenotypes in head and neck squamous cell carcinoma. J Cell
Mol Med. 22:1337–1349. 2018.PubMed/NCBI
|
|
29
|
Peng JM, Bera R, Chiou CY, Yu MC, Chen TC,
Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, et al: Actin
cytoskeleton remodeling drives epithelial-mesenchymal transition
for hepatoma invasion and metastasis in mice. Hepatology.
67:2226–2243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie K, Ye Y, Zeng Y, Gu J, Yang H and Wu
X: Polymorphisms in genes related to epithelial-mesenchymal
transition and risk of non-small cell lung cancer. Carcinogenesis.
38:1029–1035. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Natsuizaka M, Whelan KA, Kagawa S, Tanaka
K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS,
Que J, et al: Interplay between Notch1 and Notch3 promotes EMT and
tumor initiation in squamous cell carcinoma. Nat Commun.
8:17582017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao D, Besser AH, Wander SA, Sun J, Zhou
W, Wang B, Ince T, Durante MA, Guo W, Mills G, et al: Cytoplasmic
p27 promotes epithelial-mesenchymal transition and tumor metastasis
via STAT3-mediated Twist1 upregulation. Oncogene. 34:5447–5459.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang J, Xiao D, Li G, Ma J, Chen P, Yuan
W, Hou F, Ge J, Zhong M, Tang Y, et al: EphA2 promotes
epithelial-mesenchymal transition through the Wnt/β-catenin pathway
in gastric cancer cells. Oncogene. 33:2737–2747. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim J, Hyun J, Wang S, Lee C and Jung Y:
MicroRNA-378 is involved in hedgehog-driven
epithelial-to-mesenchymal transition in hepatocytes of regenerating
liver. Cell Death Dis. 9:7212018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Katsuno Y, Qin J, Oses-Prieto J, Wang H,
Jackson-Weaver O, Zhang T, Lamouille S, Wu J, Burlingame A, Xu J
and Derynck R: Arginine methylation of Smad7 by PRMT1 in
TGF-β-induced epithelial-mesenchymal transition and epithelial stem
cell generation. J Biol Chem. 293:13059–13072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee SH, Koo BS, Kim JM, Huang S, Rho YS,
Bae WJ, Kang HJ, Kim YS, Moon JH and Lim YC: Wnt/β-catenin
signalling maintains self-renewal and tumourigenicity of head and
neck squamous cell carcinoma stem-like cells by activating Oct4. J
Pathol. 234:99–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiang D, Cheng Z, Liu H, Wang X, Han T,
Sun W, Li X, Yang W, Chen C, Xia M, et al: Shp2 promotes liver
cancer stem cell expansion by augmenting β-catenin signaling and
predicts chemotherapeutic response of patients. Hepatology.
65:1566–1580. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chai S, Ng KY, Tong M, Lau EY, Lee TK,
Chan KW, Yuan YF, Cheung TT, Cheung ST, Wang XQ, et al: Octamer
4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in
liver cancer stem cells. Hepatology. 64:2062–2076. 2016. View Article : Google Scholar : PubMed/NCBI
|
